ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

595 hedge funds and large institutions have $30B invested in Alexion Pharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 218 increasing their positions, 214 reducing their positions, and 45 closing their positions.

Holders
595
Holders Change
+36
Holders Change %
+6.44%
% of All Funds
14.86%
Holding in Top 10
19
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.47%
New
88
Increased
218
Reduced
214
Closed
45
Calls
$551M
Puts
$435M
Net Calls
+$117M
Net Calls Change
-$98.3M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$748M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$124M
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$132M
4
UBS AM
4
UBS AM
Illinois
$238M
5
Alkeon Capital Management
5
Alkeon Capital Management
New York
$70.1M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.66B
2
Sands Capital Management
2
Sands Capital Management
Virginia
$670M
3
Goldman Sachs
3
Goldman Sachs
New York
$485M
4
State Street
4
State Street
Massachusetts
$1.58B
5
BlackRock
5
BlackRock
New York
$2.72B
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$3.13B 22,281,648 -537,207 -2%
BlackRock
2
BlackRock
New York
$2.72B 19,357,331 -568,934 -3%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.66B 18,958,933 -2,415,344 -11%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.11B 15,041,550 +255,719 +2%
State Street
5
State Street
Massachusetts
$1.58B 11,254,559 -606,088 -5%
BBA
6
Baker Bros. Advisors
New York
$1.2B 8,553,864 – –
Ameriprise
7
Ameriprise
Minnesota
$896M 6,390,301 +215,005 +3%
Jennison Associates
8
Jennison Associates
New York
$748M 5,332,636 +4,682,336 +720%
Sands Capital Management
9
Sands Capital Management
Virginia
$670M 4,775,947 -1,570,127 -25%
Invesco
10
Invesco
Georgia
$662M 4,717,795 +313,971 +7%
O
11
OrbiMed
New York
$511M 3,645,486 -226,300 -6%
Norges Bank
12
Norges Bank
Norway
$489M 3,488,979 -259,301 -7%
Goldman Sachs
13
Goldman Sachs
New York
$485M 3,458,227 -1,343,647 -28%
TCIM
14
TIAA CREF Investment Management
New York
$480M 3,421,950 +201,989 +6%
ClearBridge Investments
15
ClearBridge Investments
New York
$454M 3,234,754 +171,703 +6%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$447M 3,187,428 -162,393 -5%
Northern Trust
17
Northern Trust
Illinois
$425M 3,032,299 +65,663 +2%
Franklin Resources
18
Franklin Resources
California
$328M 2,340,060 -62,522 -3%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$307M 2,194,149 +32,693 +2%
Bank of America
20
Bank of America
North Carolina
$299M 2,131,085 +389,910 +22%
WRF
21
Waddell & Reed Financial
Kansas
$294M 2,096,687 +438,767 +26%
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$248M 1,794,725 +482,798 +37%
UBS AM
23
UBS AM
Illinois
$238M 1,696,942 +508,327 +43%
TCP
24
Tourbillon Capital Partners
New York
$221M 1,575,029 -73,923 -4%
Wells Fargo
25
Wells Fargo
California
$219M 1,558,531 +383,713 +33%
1
2 3 4 5